FdaApplication
NDA 212038
Identifiers
- fda_app_no: NDA212038
Properties
| Property | Value |
|---|---|
| applicant_name | KNOA PHARMA LLC |
| application_type | NDA |
| approval_date | 2019-02-27 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | 55MG | CAPSULE, EXTENDED RELEASE;ORAL |
| ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | 45MG | CAPSULE, EXTENDED RELEASE;ORAL |
| ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | 25MG | CAPSULE, EXTENDED RELEASE;ORAL |
| ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | 70MG | CAPSULE, EXTENDED RELEASE;ORAL |
| ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | 35MG | CAPSULE, EXTENDED RELEASE;ORAL |
| ADHANSIA XR | METHYLPHENIDATE HYDROCHLORIDE | 85MG | CAPSULE, EXTENDED RELEASE;ORAL |
6 products